Category: PUBLIC HEALTH INFORMATION

New Studies Suggest People Who Have Recovered From COVID-19 Should Still Get One Vaccine Dose

New research from the University of California San Francisco (UCSF) and University of Minnesota (UMN) suggest that individuals who have recovered from COVID-19 should still receive one vaccination shot. The research from UCSF was published on Sept. 25. Scientists evaluated the humoral and cell-mediated response elicited by the Pfizer-BioNTech vaccine in individuals who had contracted COVID-19 and those who…


Antibodies Persist for More Than a Year After COVID-19 Infection, Study Finds

The immune systems of the vast majority of people who have been infected with the CCP virus will continue to carry antibodies against the virus for at least 12 months, according to a peer-reviewed study accepted by the European Journal of Immunology on Sept. 24. Scientists at the Finnish Institute for Health and Welfare studied the…


AstraZeneca Says Its COVID-19 Vaccine Is 74 Percent Effective in US Testing

AstraZeneca’s COVID-19 vaccine is 74 percent effective in preventing symptomatic illness, according to data from its U.S. clinical trial published in the New England Journal of Medicine on Wednesday. The phase 3 trial involved more than 32,000 participants in the United States, Peru, and Chile, who either received two doses of the COVID-19 vaccine or…


COVID-19 Vaccine Should Not Be Mandated for Children: Dr. Scott Atlas

The COVID-19 vaccine should not be mandated for children since it does not “necessarily benefit” them like the vaccines required for school and child care, according to former White House COVID-19 adviser Dr. Scott Atlas. “Those vaccines that are mandated for children, even if you believe they should be mandated, are for diseases that are…


Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued

News Analysis Data on the effectiveness of convalescent plasma for hospitalized COVID-19 patients is still inconclusive despite more than a year since the federal authority first issued an emergency use authorization (EUA) for the therapy and many studies have been conducted. Findings from a recent randomized controlled trial suggest that convalescent plasma—the liquid component of…


New R.1 COVID-19 Variant With ‘Unique Mutations’ Discovered at Kentucky Nursing Home

A new variant of the COVID-19 virus has been discovered at a Kentucky nursing home, where it reportedly infected 45 residents and health care personnel, according to scientist William A. Haseltine. The variant, called R.1, originated in Japan and infected many residents and workers in the nursing home who were fully vaccinated, Haseltine said. R.1 now received over 10,000…


Is COVID-Deaths Data Being Manipulated for Profit? Doctor Sues University Over Mandatory Vaccine Policy

Should people who have recovered from COVID-19 and are naturally immune be expected to get vaccinated? Dr. Aaron Kheriaty, professor of psychiatry and behavioral science at the University of California–Irvine, is adamant that they should not. He’s suing the school system’s president and Board of Regents over its coronavirus vaccination mandate. “I’m going to be…


Older People and Men ‘More Likely to Suffer’ With COVID-19 Even After Two Jabs: UK Report

Older people, men, and those from ethnic backgrounds are more likely to end up in the hospital or die even after they have been double-vaccinated against COVID-19, researchers say. Scientists used a range of data to show that while the risk of severe COVID-19 after vaccination remains low, some people are at greater risk than…


EU Regulator Unable to Confirm If Women Face Increased Clot Risks After AstraZeneca Shot

Europe’s drug regulator said on Friday that it could not confirm whether AstraZeneca’s COVID-19 vaccine has any influence on higher risks for unusual blood clots associated with low levels of blood platelets in women and younger adults. The European Medicine Agency (EMA) said in a statement it was requested by the European Commission to provide…


FDA Panel Votes 16-3 Against Approving Pfizer COVID-19 Booster Shots

The U.S. Food and Drug Administration (FDA) advisory panel on Friday voted 16-3 to recommended against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older. Throughout the meeting, independent scientists to the FDA struck a skeptical tone on the need for boosters, or third doses, for Pfizer’s mRNA COVID-19 vaccine…